Rogg L, Nunez SA, Mingrone MV, Domingo P, et al. Proof-of-Concept Phase 2a Trial of VH4524184 (VH-184), an Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile. Clin Infect Dis 2026 Jun 12:ciag357. doi: 10.1093.
PMID: 42283218